Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03536559
Brief Title: Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (VISIONARY-MS)

First Submitted : May 2, 2018
First Submitted that Met QC Criteria : May 14, 2018
First Posted : May 24, 2018

Last Update Submitted that Met QC Criteria : April 29, 2021
Last Update Posted : April 30, 2021